*
Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice
54321Not Applicable
Evaluate the effects of comprehensive lifestyle changes, such as diet, exercise, and education, on clinical markers that are riskfactors for cardiovascular disease.
Implement evidence-based recommendations for the medical and surgical management of obesity to improve patient outcomes.
Apply current cholesterol lowering therapy guidelines to reduce the risk of heart attack and stroke.
Interpret the results and conclusions of the most relevant studies that evaluate the role of HDL as a CVD risk factor.
Examine cardiovascular risk related to triglyceride-rich lipoproteins.
Examine the National Lipid Association recommendations for patient-centered management of dyslipidemia.
Identify new technologies that are being developed to further advance the minimally invasive and interventional treatment of valvular heart disease.
Examine prevention, reversal and treatment strategies for heart failure, considering medical and surgical options.
Demonstrate the role of atherosclerosis imaging testing in CVD risk reclassification to guide management decisions.
Recognize the latest and emerging interventional radiology technology and procedures poised to improve the testing, diagnosis and management of cardiovascular disease.
Scoring key: 5=Very effective, 4= Effective, 3= Somewhat effective, 2= Slightly effective, 1= Completely Ineffective, N/A= Not Applicable
*
54321Not Applicable
Cardiovascular Disease Prevention 2017: Overview - Michael Ozner, M.D.
The Role of Omega-3 Fatty Acids in CVD Prevention - Carl Lavie, M.D.
Coffee Consumption: Healthy or Harmful? - Natalie Castro, R.D.
Exercise as a Therapeutic Agent in the 21st Century: Emphasis on Efficacy, Dosing, Adverse Effects/Toxicity - Carl Lavie, M.D.
Nutrition Facts: What We Need to Know - Natalie Castro, R.D.
Phytosterols as Functional Food to Improve Heart Health: Fact or Fiction? - Thomas Dayspring, M.D.
Alcohol and Cardiovascular Health: The Razor-Sharp Double-Edged Sword - Carl Lavie, M.D.
Lipoprotein (a) in Clinical Practice: Whom to Treat? When to Treat? How to Treat? - Paul Ziajka, M.D.
Strategies to Reduce Residual Risk - Thomas Dayspring, M.D.
Familial Hypercholesterolemia: Clinicla Update - Paul Ziajka, M.D.
Obstructive Sleep Apnea: The Often Neglected CVD Risk Factor - Timothy Grant, M.D.
"Smoldering" Insulin Resistance: Strategies to Optimize Cardiometabolic Health - Thomas Dayspring, M.D.
*
54321Not Applicable
Obesity: Evaluation and Treatment - Theodore Feldman, M.D.
Weighing the "Heavy" Cardiovascular Burden on Obesity and the "Obesity Paradox" - Carl Lavie, M.D.
Metabolic Syndrome: Prevention and Management Strategies - Roger Blumenthal, M.D.
The Role of Bariatric Surgery - Anthony Gonzalez, M.D.
The Role of Exercise in Weight Loss and Maintenance - Carl Lavie, M.D.
Role of Non-Statin Therapy in CV Risk Reduction - James Underberg, M.D.
Valvular Heart Disease: From Prevention to Intervention - Ramon Quesada, M.D.
Blood Pressure Guidelines: Consensus and Controversy - William Cushman, M.D.
Achieving Harmony in Blood Pressure Guidelines Around the Globe - Roger Blumenthal, M.D.
Resistant Hypertension: Management Strategies - William Cushman, M.D.
Examining Areas in Need of Modification in the 2013 Prevention Guidelines - Roger Blumenthal, M.D.
NLA Recommendations for Patient-Centered Management of Dyslipidemia - James Underberg, M.D.
Newly Defined Features of PCSK9 and Lipoprotein Metabolism - Peter Toth, M.D.
PCSK9 Therapy in Real Life: Narnia Vs. Healthcare Bankruptcy - Sergio Fazio, M.D.
*
54321Not Applicable
Can the Atherosclerotic Plaque Regress? - Sergio Fazio, M.D.
The Future of HDL Diagnostics and Therapeutics - Sergio Fazio, M.D.
Triglycerides on the Rise: Is It Time to Swap Seats on the HDL/TG Teeter-Totter? - Peter Libby, M.D.
The Role of Apolipoprotein CIII in Coronary Artery Disease - William Virgil Brown, M.D.
Elevated Triglycerides: Lifestyle and Pharmaceutical Intervention - Peter Toth, M.D.
Inflammation in Atherosclerosis: A Translational Journey - Peter Libby, M.D.
Heart Disease in Women: Putting Prevention Into Practice - Karol Watson, M.D.
Hormone Replacement Therapy in Women: Has the Last Chapter Been Written? - Karol Watson, M.D.
From Xamthomata to Coronary Artery Disease: The Trail to the LDL Receptor - William Virgil Brown, M.D.
Non-HDL Cholesterol Vs. Apo B for CVD Risk Assessment: And the Winner is.. - Peter Toth, M.D.
When Prevention Fails: Interventional Cardiology for Acute and Chronic Ischemia - Ramon Lloret, M.D.
Heart Failure Update: Reducing Hospitalizations and Improving Patient Outcomes - Julio Barcena, M.D.
*
54321Not Applicable
Coronary Calcium Scoring for Optimal Risk Stratification - Khurram Nasir, M.D.
Coronary CT imaging in Everyday Practice - Arthur Agatston, M.D.
Stroke Prevention Guidelines - Ian Del Conde, M.D.
Management of Acute Stroke: A Paradigm Shift - Felipe De Los Rios La Rosa, M.D.
Deep Vein Thrombosis: Evidence-Based Prevention and Treatment - Ian Del Conde, M.D.
Atrial Fibrillation: Medical Therapy and Catheter Ablation - Efrain Gonzalez, M.D.
Endovascular Repair of Abdominal Aortic Aneurysms - Constantino Pena, M.D.
*
*
YesNoNot Applicable
Increased my knowledge
Enhanced my performance
Improved my competence
Ensured that my patients will have improved outcomes
*
*
*
*
*
*
*
*
*
*
*